Removing "flavor" from pathogenic antibodies hits a therapeutic sweet spot

Sci Immunol. 2024 Dec 6;9(102):eadu8805. doi: 10.1126/sciimmunol.adu8805. Epub 2024 Dec 6.

Abstract

Endoglycosidase CU43 removes IgG Fc glycans, inhibits IgG effector functions, and prevents pathology in multiple disease models.

MeSH terms

  • Animals
  • Glycoside Hydrolases / immunology
  • Humans
  • Immunoglobulin Fc Fragments / immunology
  • Immunoglobulin G* / immunology
  • Mice

Substances

  • Immunoglobulin G
  • Glycoside Hydrolases
  • Immunoglobulin Fc Fragments